Evidence map›Paper›PMID 35846074›Full record

ArticleImplementation research and practice

Implementation of a clinical pathway to screen and treat medical inpatients for opioid withdrawal.

Kimberly D Williams, Beverly L Wilson, Claudine T Jurkovitz, Jo A Melson, Jeffrey A Reitz, Carmen K Pal, Sherry P Hausman, Erin Booker, Linda J Lang, Terry L Horton

Open access · goldAbstract read
In one paragraph

Article in Implementation research and practice. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Kimberly D WilliamsInstitute for Research on Equity and Community Health, ChristianaCare, Wilmington, DE, USA.ORCID 0000-0003-0630-5107
Beverly L WilsonBehavioral Health, ChristianaCare, Wilmington, DE, USA.
Claudine T JurkovitzInstitute for Research on Equity and Community Health, ChristianaCare, Wilmington, DE, USA.
Jo A MelsonDepartment of Nursing, ChristianaCare, Wilmington, DE, USA.
Jeffrey A ReitzDepartment of Pharmacy, ChristianaCare, Wilmington, DE, USA.
Carmen K PalIT Clinical Application Services, ChristianaCare, Wilmington, DE, USA.
Sherry P HausmanData Informatics and Analytics, ChristianaCare, Wilmington, DE, USA.
Erin BookerBehavioral Health, ChristianaCare, Wilmington, DE, USA.
Linda J LangBehavioral Health, ChristianaCare, Wilmington, DE, USA.
Terry L HortonBehavioral Health, ChristianaCare, Wilmington, DE, USA.
Christiana Care Health System · USInstitute for Community Health · US

Funding

Subproject Title: Clinical Research Education, Mentoring and Career Development CoreU54GM104941 · NIGMS · UNIVERSITY OF DELAWARE · PI Susan Poland Giancola · 2013 to 2026
$60.5M
NIGMS NIH HHS U54 GM104941
6 · The paper itself

Abstract

Background: Opioid-related inpatient hospital stays are increasing at alarming rates. Unidentified and poorly treated opioid withdrawal may be associated with inpatients leaving against medical advice and increased health care utilization. To address these concerns, we developed and implemented a clinical pathway to screen and treat medical service inpatients for opioid withdrawal. Methods: The pathway process included a two-item universal screening instrument to identify opioid withdrawal risk (Opioid Withdrawal Risk Assessment [OWRA]), use of the validated Clinical Opiate Withdrawal Scale (COWS) to monitor opioid withdrawal symptoms and severity, and a 72-h buprenorphine/naloxone-based treatment protocol. Implementation outcomes including adoption, fidelity, and sustainability of this new pathway model were measured. To assess if there were changes in nursing staff acceptability, appropriateness, and adoption of the new pathway process, a cross-sectional survey was administered to pilot four hospital medical units before and after pathway implementation. Results: Between 2016 and 2018, 72.4% (77,483/107,071) of admitted patients received the OWRA screening tool. Of those, 3.0% (2,347/77,483) were identified at risk for opioid withdrawal. Of those 2,347 patients, 2,178 (92.8%) were assessed with the COWS and 29.6% (645/2,178) were found to be in active withdrawal. A total of 49.5% (319/645) patients were treated with buprenorphine/naloxone. Fifty-seven percent (83/145) of nurses completed both the pre- and post-pathway implementation surveys. Analysis of the pre/post survey data revealed that nurse respondents were more confident in their ability to determine which patients were at risk for withdrawal ( Conclusions: Our study demonstrates a process for successfully implementing and sustaining a clinical pathway to screen and treat medical service inpatients for opioid withdrawal. Standardizing care delivery for patients in opioid withdrawal can also improve nursing confidence when working with this complex population.

Indexed as

addiction medicineClinical Opiate Withdrawal Scaleclinical pathwayinpatient medicineopioid use disorderopioid withdrawal

Identifiers

PMID35846074
PMCPMC9281054
OpenAlexW4285797155

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.